Diterpenoids from Roots of Salvia lachnocalyx; In-silico and In-vitro Toxicity against Human Cancer Cell Lines

Document Type : Research article

Authors

1 Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Department of Molecular Physiology, Agricultural Biotechnology Research Institute of Iran, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Abstract

Further investigations on phytochemical constituents of dichloromethane extract from
roots of Salvia lachnocalyx (S. lachnocalyx) led to the isolation and identification of eight
known diterpenoids from this plant for the first time. The chemical structures of the purified
compounds were elucidated using spectroscopic analyses including EI-MS, 1H and 13C NMR and
by comparison of the resulting spectra with those reported in the literature. Then, the cytotoxic
activity of identified compounds was examined against two human cancer cell lines MCF-7
(human breast adenocarcinoma) and K562 (human chronic myelogenous leukemia). Molecular
docking of promising cytotoxic compounds were performed by AutoDock Tools 1.5.4 program
in the active site of Topoisomerase I. Eight known diterpenoids; 12-hydroxysapriparaquinone
(1), 15-deoxyfuerstione (2), horminon (3), 7α-acetoxyroyleanone (4), 11β-hydroxymanoyl
oxide (5), microstegiol (6), 1-keto-aethiopinone (7) and 14-deoxycoleon U (8) were isolated of
dichloromethane extract from roots of salvia lachnocalyx. Compounds 2, 3, 6, and 8 showed
cytotoxic activity against MCF-7 (human breast adenocarcinoma) and K562 (human chronic
myelogenous leukemia) cell lines with IC50 values in the range of 2.63-11.83 μg/mL. The inhibition
of” topoisomerase I” was suggested by molecular docking calculations as the mechanism of
cytotoxicity of the tested compounds. According to cytotoxic assay and docking results, it is
suggested that compounds 2, 3, 6, and 8 have good potential as anticancer agents.

Graphical Abstract

Diterpenoids from Roots of Salvia lachnocalyx; In-silico and In-vitro Toxicity against Human Cancer Cell Lines

Keywords


  1. Jassbi AR, Zare S, Firuzi O, Xiao J. Bioactive phytochemicals from shoots and roots of Salvia species. Phytochemistry reviews. 2016;15(5):829-67.
  2. Asadollahi, M., Firuzi, O., Heidary Jamebozorgi, F., Alizadeh, M., Jassbi, A. R. Ethnopharmacological studies, chemical composition, antibacterial and cytotoxic activities of essential oils of eleven Salvia in Iran. J. Herbal Med. https://doi.org/10.1016/j.hermed.2018.11.006.
  3. Hadavand Mirzaei H, Firuzi O, Baldwin IT, Jassbi AR. Cytotoxic activities of different iranian solanaceae and lamiaceae plants and bioassay-guided study of an active extract from Salvia lachnocalyx. Natural Product Communications. 2017;12(10):1563-6.
  4. Jamzad Z. Lamiaceae in Assadi. M, Maassoumi, A, Mozaffarian, V(eds), Flora of Iran. 2012(76).
  5. Farimani MM, Mazarei Z. Sesterterpenoids and other constituents from Salvia lachnocalyx Hedge. Fitoterapia. 2014;98:234-40.
  6. Mirza M, Bahernik Z. Extraction and identification of the essential oil components of Salvia lachnocalyx Hedge. Iran J. Med. Aroma. PLANTS. 2007; 23: 278-284.
  7. Mirzaei HH, Firuzi O, Schneider B, Baldwin IT, Jassbi AR. Cytotoxic diterpenoids from the roots of Salvia lachnocalyx. Revista Brasileira de Farmacognosia. 2017;27(4):475-9.
  8. Chen X, Ung CY, Chen Y. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? Natural product reports. 2003;20(4):432-44.
  9. Osguthorpe DJ, Sherman W, Hagler AT. Generation of receptor structural ensembles for virtual screening using binding site shape analysis and clustering. Chemical biology & drug design. 2012;80(2):182-93.
  10. Firuzi O, Miri R, Asadollahi M, Eslami S, Jassbi AR. Cytotoxic, antioxidant and antimicrobial activities and phenolic contents of eleven Salvia species from Iran. Iranian journal of pharmaceutical research: IJPR. 2013;12(4):801.
  11. Topcu G, Eriş C, Ulubelen A. Rearranged abietane diterpenes from Salvia limbata. Phytochemistry. 1996;41(4):1143-7.
  12. Michavila A, María C, Rodríguez B. 20-Nor-abietane and rearranged abietane diterpenoids from the root of Salvia argentea. Phytochemistry. 1986;25(8):1935-7.
  13. Simões F, Michavila A, Rodríguez B, Maria C, Hasan M. A quinone methide diterpenoid from the root of Salvia moorciuftiana. Phytochemistry. 1986;25(3):755-6.
  14. Jassbi AR, Mehrdad M, Eghtesadi F, Ebrahimi SN, Baldwin IT. Novel rearranged abietane diterpenoids from the roots of Salvia sahendica. Chemistry & biodiversity. 2006;3(8):916-22.
  15. Jassbi AR, Eghtesadi F, Hazeri N, Ma’sumi H, Valizadeh J, Chandran JN et al. The roots of Salvia rhytidea: a rich source of biologically active diterpenoids. Natural product research. 2017;31(4):477-81.
  16. Fraga BM, Díaz CE, Guadaño A, González-Coloma A. Diterpenes from Salvia broussonetii transformed roots and their insecticidal activity. Journal of agricultural and food chemistry. 2005;53(13):5200-6.
  17. Topcu G, Tan N, Ulubelen A, Sun D, Watson W. Terpenoids and flavonoids from the aerial parts of Salvia candidissima. Phytochemistry. 1995;40(2):501-4.
  18. Ulubelen A, Topcu G, Tan N, Lin L-J, Cordell GA. Microstegiol, a rearranged diterpene from Salvia microstegia. Phytochemistry. 1992;31(7):2419-21.
  19. Amslinger S. The Tunable Functionality of α, β‐Unsaturated Carbonyl Compounds Enables Their Differential Application in Biological Systems. ChemMedChem. 2010;5(3):351-6.
  20. Liu LF. DNA topoisomerase poisons as antitumor drugs. Annual review of biochemistry. 1989;58(1):351-75.
  21. Han HJ, Tan NH, Zeng GZ, Fan JT, Huang HQ, Ji CJ et al. Natural inhibitors of DNA topoisomerase I with cytotoxicities. Chemistry & biodiversity. 2008;5(7):1364-8.
  22. Fronza M, Lamy E, Günther S, Heinzmann B, Laufer S, Merfort I. Abietane diterpenes induce cytotoxic effects in human pancreatic cancer cell line MIA PaCa-2 through different modes of action. Phytochemistry. 2012;78:107-19.
  23. Ioanoviciu A, Antony S, Pommier Y, Staker BL, Stewart L, Cushman M. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. Journal of medicinal chemistry. 2005;48(15):4803-14.
  24. Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L et al. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. Journal of medicinal chemistry. 2005;48(7):2336-45.
  25. Staker BL, Hjerrild K, Feese MD, Behnke CA, Burgin AB, Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proceedings of the National Academy of Sciences. 2002;99(24):15387-92.
  26. Lauria A, Ippolito M, Almerico AM. Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database. Journal of molecular modeling. 2007;13(3):393-400.